SynopsisIt is used to treat leukemia and certain types of cancer of the breast, skin, head and neck, or lung. The global Methotrexate Injection market was valued at US$ 155.2 million in 2023 and is anticipated to reach US$ 182.8 million by 2030, witnessing a CAG.....
SynopsisMedical air compression system is a device used to provide positive pressure air to support a patient's breathing or surgical anesthesia for a ventilator, anaesthesia machine, etc. The global Medical Air Compression System market was valued at US$ millio.....
SynopsisThe global Stem Cell Growth Factors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Stem Cell Growth Factors is estimated to .....
SynopsisThe Oral Anesthesia Booster is a special medical device for dentistry, which is mainly used in the treatment of teeth to assist in the process of anesthesia injection. The global Oral Anesthesia Booster market was valued at US$ million in 2023 and is ant.....
SynopsisThe global Emergency Eyewash and Showers market was valued at US$ 887.6 million in 2023 and is anticipated to reach US$ 1067.9 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030. North American market for Emergency Eyewash an.....
SynopsisGlobal Ultrasonic Skin Cleaner market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have .....
SynopsisA bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recogn.....
Synopsis Global Dermatology Treatment Devices market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Ru.....
SynopsisInhaler can be taken in pocket. Inhalers also deliver medication more quickly. Global Inhalation Combination Product market is projected to reach US$ 17280 million in 2029, increasing from US$ 13470 million in 2022, with the CAGR of 3.7% during the perio.....
SynopsisTofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis The global Xeljanz (tofacitnib) Drug market was valued at US$ 1754 million in 2023 and is anticipated .....
